Sensei Biotherapeutics Acquires Faeth Therapeutics

Leila Ahmed North America Legal Chronicle
Tagged:

Sidley has advised Sensei Biotherapeutic on the transaction. Cooley has advised Faeth Therapeutics. Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a Nasdaq-listed clinical-stage biotechnology company, has acquired Faeth…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here